Authors:
Markey, P
Krause, V
Boslego, JW
Coplan, PM
Dargan, JM
Kaplan, KM
Citation: P. Markey et al., The effectiveness of Haemophilus influenzae type b conjugate vaccines in ahigh risk population measured using immunization register data, EPIDEM INFE, 126(1), 2001, pp. 31-36
Authors:
Linglof, T
van Hattum, J
Kaplan, KM
Corrigan, J
Duval, I
Jensen, E
Kuter, B
Citation: T. Linglof et al., An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA((R))) in adults: safety, tolerability, and immunogenicity (vol19, pg 3968, 2001), VACCINE, 20(1-2), 2001, pp. 281-281
Authors:
Hornick, R
Tucker, R
Kaplan, KM
Eves, KA
Banerjee, D
Jensen, E
Kuter, B
Citation: R. Hornick et al., A randomized study of a flexible booster dosing regimen of VAQTA (R) in adults: safety, tolerability, and immunogenicity, VACCINE, 19(32), 2001, pp. 4727-4731
Authors:
Linglof, T
van Hattum, J
Kaplan, KM
Corrigan, J
Duval, I
Jensen, E
Kuter, B
Citation: T. Linglof et al., An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA((R))) in adults: safety, tolerability, and immunogenicity, VACCINE, 19(28-29), 2001, pp. 3968-3971
Authors:
Vessey, SJR
Chan, CY
Kuter, BJ
Kaplan, KM
Waters, M
Kutzler, DP
Carfagno, PA
Sadoff, JC
Heyse, JF
Matthews, H
Li, S
Chan, ISF
Citation: Sjr. Vessey et al., Childhood vaccination against varicella: Persistence of antibody, durationof protection, and vaccine efficacy, J PEDIAT, 139(2), 2001, pp. 297-304
Citation: Jf. Heyse et Km. Kaplan, The reactogenicity and immunogenicity of commercial Haemophilus influenzaetype b conjugate vaccines, EUR J PED, 159(12), 2000, pp. 932-932
Authors:
Dargan, JM
Coplan, PM
Kaplan, KM
Nikas, A
Citation: Jm. Dargan et al., Reemergence of invasive Haemophilus influenzae type b disease in Alaska: Is it because of vaccination with polyribosylribitol phosphate outer membrane protein complex (PRP-OMPC) or failure to vaccinate with PRP-OMPC?, J INFEC DIS, 181(2), 2000, pp. 806-808